CC-401

· Celgene Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CC-401, covering 2007-05-15 to 2007-05-15. Get the full timeline:

Most recent: Clinical Trial Update: Study to Determine the Optimal Biologic Dose of CC-401 in Subjects With High-Risk Myeloid Leukemia [Phase 1]